Recrudescence, which can be asymptomatic, increases the risk of transmission. BV infection in humans can result in serious clinical symptoms and is often lethal (Holmes et al. 1995) . In addition, it also causes fatal disease in several non-macaque species such as patas monkeys (Erythrocebus patas), black and white colobus (Colobus abyssinicus), capuchin monkeys (Cebus apella), common marmosets (Callithrix jacchus) and debrazza's monkeys (Cercopithecus neglectus) (Gay & Holden 1933 , Loomis et al. 1981 , Wilson et al. 1990 , Weigler 1992 .
This report describes detection of a persistent but asymptomatic BV infection
A natural asymptomatic herpes B virus infection in a colony of laboratory brown capuchin monkeys (Cebus apella)
in a colony of New World monkeys (Cebus apella). It is likely that the infection was contracted through indirect contact with BV-infected macaques housed in the same room but in different cages.
Materials and methods
Animals and housing conditions Colony history The capuchin monkey colony (four males and three females) was part of a collection of several non-human primate species in the research facility of Aventis Pharma in Frankfurt, Germany. The colony was set up in 1977 with wild caught animals from Costa Rica and was never restocked with external animals. The only additions were animals bred in-house.
In April 1997, the collection consisted of 27 rhesus macaques (Macaca mulatta), four cynomolgus monkeys (Macaca fascicularis), three stump-tailed macaques (Macaca arctoides), 11 squirrel monkeys (Saimiri sciureus) and eight capuchin monkeys (Cebus apella), including one suckling offspring that was too young to test.
Since most of the animals were kept over a very long period in the research department in different buildings, and in various breeding and housing groups, it was not possible to follow their detailed housing history over the years.
After 1985 when the last rhesus and 1992 the last cynomolgus monkeys were brought to the colony no external monkeys were introduced until September 1993 when two rhesus were added. In February 1994 one rhesus and in April 1994 another five rhesus entered the colony.
In all species the housing was changed from single housing to group housing in custom-made enclosures of various sizes. Some of the macaques' enclosures had an outside run. All enclosures exceeded by far the dimensions recommended by the relevant guidelines and were equipped with various enrichment devices. The macaque species were kept in several buildings with frequent direct intra-species contact either for breeding and/or during experiments. Since different macaque species were housed in the same area but in different enclosures, indirect inter-species contact via caretakers at feeding or cleaning is highly probable. The capuchin group was kept in the same room with one rhesus group. This capuchin enclosure, however, was physically separated thereby preventing direct contact between rhesus and capuchins. Indirect contact through aerosol, dust or via caretakers cannot be excluded. In the period between 1994 and 1997 the capuchins were moved out of contact with the rhesus. During this time the capuchins shared a room with the squirrel monkeys, again with only indirect contact via the caretakers.
The monkeys were investigated regularly for salmonellosis and for tuberculosis. In March 1994 the first serological test for BV was performed by Charles River Laboratories, Wilmington, USA in all monkeys. All samples were tested negative.
In late December 1996 one rhesus showed clinical lesions of the genital and oral mucosa which could be interpreted as signs of BV infection. A clinical differential diagnosis of Herpes genitalis and/or buccalis was made. As a consequence of the clinical case, in February 1997 all monkeys (excluding the squirrel monkeys) were serologically tested at the Simian Diagnostic Laboratory, Virus Reference Laboratory in San Antonio, USA, and resulted in positive findings for BV. The test was repeated with new samples and the positive results were confirmed. Samples were also sent to the Public Health Laboratory Services (PHLS, London, UK) and the American results were essentially confirmed. The results of the investigations showed seropositivity in four of 25 tested rhesus, two of three stump-tailed macaques, none of four cynomolgus and five of eight capuchin monkeys (one of the five capuchins was equivocal in the COMPRIA test and slightly positive in the neutralization test).
All seropositive rhesus and all stumptailed macaques were euthanized and necropsied at Paul Ehrlich Institute (PEI, Langen, Germany) without any further findings pointing to a BV infection. The rhesus that had shown clinical signs was seropositive but did not show any relevant changes at necropsy. From the seropositive findings of the capuchin monkeys it was not possible to determine if these antibodies were homologous to BV or raised against heterologous, antigenetically similar alpha-herpesviruses which have been isolated from other South American species (Herpesvirus saimiri-1, Herpesvirus ateles-1 in squirrel and spider monkey, respectively). The PHLS speculated on the possibility of this being an antibody to a capuchin monkey alpha-herpesvirus as, based on prevailing information, the capuchins would normally have succumbed to BV. It was concluded that the capuchins were not BV infected. We were however advised by PHLS that these monkeys be assumed to have been infected with a potential non-BV human pathogen based on the cross-species transmission data with primate alpha-herpesviruses. Therefore, we decided to keep the capuchins but introduced suitable isolation procedures.
In conclusion, the somewhat incomplete colony history indicated that the capuchins became seropositive between 1994, the time of the first negative BV test and 1997, when positive BV results were found and the species were separated.
All remaining rhesus monkeys were concentrated and separated off in one single barrier unit with several enclosures in pair or group housing. The access was limited and people had to change into protective clothes including goggles and gloves, which were discarded on leaving the barrier. The whole capuchin group was allowed to survive and housed in a second barrier unit with less stringent access restrictions. The squirrel monkeys had been given to a zoo and the cynomolgus monkeys were given to another research institute.
In April 1999 a retest at PHLS of the remaining 22 rhesus monkeys resulted in entirely negative findings.
Following a management decision to close the primate facility at Aventis Pharma in Frankfurt, all rhesus were transferred to other research institutions by 2001. However, any attempt to find a research facility willing to take the capuchin monkeys failed. Before giving the animals to a private zoo, they were retested for BV at the PHLS in February 2001. The results showed that five of seven animals tested were seropositive and it was considered too risky to give potentially BV-infected animals to private care. At the PEI, parallel attempts were made to check the unexpected results of PHLS. The positive results were confirmed by polymerase chain reaction (PCR) and serology and, after consultation with the responsible authorities, the animals were euthanized and investigated further.
Samples
In vivo sampling and euthanasia were carried out at the Animal Facilities, Aventis Pharma, Frankfurt. Samples for serological testing and BV PCR were collected from the capuchin monkeys after anaesthesia with a mixture of 2.5 mg xylazine hydrochloride (Rompun ® TS, Bayer, Leverkusen, Germany) and 5.0 mg ketamine hydrochloride (Ketamin 10%, WDT, Garbsen, Germany) per kg body weight injected i.m. into the thigh. The animals were assumed to be anaesthetized when they became immobile and the eye reflexes stopped. Blood samples were collected from the femoral vein using the vacutainer system (Becton and Dickinson GmbH, Heidelberg, Germany).
For oral sampling, the mouth mucosa was gently wiped thoroughly with a sterile swab (Heiland Vet. GmbH and Co. KG, Hamburg, Germany). For ocular sampling, the surface of the eyeball and the conjunctiva were wiped with a swab moistened with sterile PBS. The swab samples were placed into tubes with 2 ml of PBS and stored at -70ЊC.
After sampling, the animals were euthanized with 5 ml of T61 (Intervet Deutschland GmbH, Unterschleißheim, Germany) given intravenously. The carcasses were transported immediately to the PEI in Langen for necropsy where there were suitable facilities for handling potentially infected materials.
Necropsy, histopathology and immunohistology
Necropsy was performed approximately one hour after euthanasia (transport time).
Organs (brain, nerve, ganglia, liver, kidney, heart, etc.) were fixed either with 4% formaldehyde solution or methanol (100%) for at least 24 h. Tissue samples were embedded in paraffin wax, 4 m slides were prepared and haematoxylin-eosin staining was performed according to standard procedures. In addition, immunohistology was performed with a monoclonal antibody specific for Herpes simplex virus (Biodesign, Asbach, Germany) according to standard methods.
Serological assays
Serological BV testing was done at the PHLS using BV specific monoclonal antibodies in a competitive radioimmunoassay (Norcott & Brown 1993) . For comparison the same samples were retested at PEI using the Enzygnost ® Anti-HSV/IgG Test Kit (DADE Chiron, Marburg, Germany). The test was optimized by using peroxidase conjugates with anti-monkey IgG (Nordic Immunological Laboratories, Tilburg, The Netherlands) instead of anti-human IgG for detection of anti-herpesvirus IgG antibodies in monkey serum samples.
Polymerase chain reaction
The PCR method here described is based on a previously unpublished method developed for the specific diagnosis of BV in rhesus using the primers shown in Table 1 .
NP40 inactivated BV propagated in Vero cells (kindly provided by Professor Schmitt, Bernhard Nocht Institute, Hamburg) and a cloned 3.7 kb fragment of the glycoprotein C (gC) region (kindly provided by Dr Huemer, University of Innsbruck) were used as positive controls. DNA from all samples was extracted using the QIAamp Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
The final incubation volume was 50 l, containing the following components: 10 l of the sample DNA, 50 mM KCl, 2 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3), 200 M (each) of dNTP, 15 pMol sense and antisense primer, 1 M betaine, and 1.25 units AmpliTaq Gold DNA polymerase (PE Applied Biosystems, Weiterstadt, Germany). The reaction was run with one cycle at 95ЊC for 10 min, 60ЊC for 30 s, and 72ЊC for 40 s, followed by 39 cycles at 95ЊC for 30 s, 60ЊC for 30 s, and 72ЊC for 40 s, and a final elongation step of 7 min at 72ЊC. The nested PCR was performed with 2 l of the first reaction product in a 50 l reaction mixture containing 50 mM KCl, 2 mM MgCl 2 , 10 mM Tris HCl (pH 8.3), 200 M (each) of dNTP, 1 M of each internal primer, 1 M betaine, and 1.25 units AmpliTaq Gold DNA polymerase. The cycle programme was identical to the first PCR run, except the annealling temperature of 56ЊC. The amplified DNA was separated on an agarose gel and visualized by ethidium bromide staining on an UV illuminator. Procedures designed to avoid contamination were strictly applied throughout the studies (Kwok & Higuchi 1989) . For DNA sequencing an aliquot of the amplified PCR product was directly cloned into the pCR2.1 vector with TA cloning system under the conditions suggested by the manufacturer (Invitrogen BV, Leek, The Netherlands). Plasmid DNA with an insert of the expected size was sequenced with the inner sense primer by using the 373 DNA Sequencer Stretch Line (PE Applied Biosystems, Weiterstadt, Germany). 
Results

Clinical symptoms
The capuchin monkeys did not show any clinical signs of disease or lesions in the mucosa of the mouth or genitals at the time of swab sampling.
Serological and PCR survey
The results of the serology and PCR testing are shown in Table 2 . The obtained sequences of the amplification products were identical to the published BV sequence of the gC region in GenBank (Accession No: AJ012474). Each animal was BV positive in at least one of the tests in 2001. PCR detected BV in each animal.
Pathology
Macroscopically, no evidence of a BV infection could be detected. Histologically, one animal (No. 29) showed a clear perivascular lymphoid infiltration around one vessel in the brain cortex. However, immunohistology specific for Herpes simplex virus did not demonstrate any specific reaction.
Discussion
BV is usually highly pathogenic in non-macaque primates including humans. The BV infection cases reported for those vulnerable species occurred mostly by either occupational (Weigler 1992 , Holmes et al. 1995 or housing contact with macaques (Loomis et al. 1981 , Wilson et al. 1990 , Weigler et al. 1993 . In this report, direct contact between macaques and capuchin monkeys allowing bites or scratches was neither noticed nor likely, but cannot be excluded. Indirect contact via contaminated protective clothes of personnel or via aerosolized excretions seems probable. It is noteworthy that the caretakers did not change their protective clothing during the daily care of both monkey species. The rhesus monkeys housed in the same room were found to be BV positive 5 years before and were euthanized immediately due to the high infection risk for the caretakers. At the same time, five of the capuchin monkeys were also BV seropositive. However, there were some doubts about the specificity of the serological assay in respect to cross-reaction with a presumed (at that time unidentified) capuchin monkey alpha-herpesvirus, which, had it existed, would be closely related to BV. Therefore, the animals were considered to be a potential risk to the caretakers and were kept under heightened isolation conditions. Based on prevailing advice and information there was not enough justification for euthanasia of these animals for safety reasons.
Enzygnost ® Anti-HSV/IgG is an enzyme immunoassay to detect human IgG antibodies against Herpes simplex virus (HSV). The anti-human IgG/horse radish peroxidase Table 2 , Animal 21M) tested 5 years ago. At that time this animal was BV seronegative and seroconverted in the meantime, suggesting that the animal was either already infected without seroconversion or BV spread within the colony in the past 5 years. We cannot exclude a false seronegative result at the time, however the PHLS result from 1997 was clearly negative.
Rapid diagnosis of BV and consequent antiviral treatment is essential for the human patient's survival. For this purpose, specific PCR is a reliable diagnostic tool which needs to be standardized and used in laboratories involved in routine BV diagnosis.
By means of PCR, BV DNA was detected in each animal regardless of its serological status. Consequently, all capuchin monkeys were indeed shown to be infected with BV, even though no clinical signs were seen at any time. It is of importance that seronegative (below the detection limit) animals can harbour and shed BV. If these animals are implicated in an injury to humans, PCR testing should be performed at once. Since BV virus was detectable in only the oral swab of Animal 29, PCR testing should necessarily include ocular and oral swabs as well as blood samples. Similar results were reported by Huff et al. (2003) who used real-time PCR to detect BV in mucosal swabs of rhesus macaques.
Unfortunately, no samples for PCR testing were taken from the BV-infected macaques at the time of necropsy at PEI in 1997. Unlike Ohsawa et al. (2002) , we could therefore not compare the sequences of BV DNA found in the capuchins with those of the rhesus to investigate whether they were indeed the source of the BV infection. Unlike Ohsawa et al. (2002) , as we detected BV in swabs and/or serum, it was not necessary for us to assay the trigeminal nerve, which is tested only when other samples give negative or poor results. The comparison of the obtained BV sequences with those sequences published by Ohsawa et al. (2002) is not possible due to the amplification of different BV regions.
Although some authors (Weir et al. 1993 ) using traditional virus isolation methods reported that the shedding of BV even from seropositive animals is uncommon, PCR based virus detection was successful when the classical virus isolation failed (Slomka et al. 1997) .
Despite the shortcomings expressed in our study, i.e. lack of comparison data with the original macaques and the fact that our PCR is designed for rhesus BV, our results indicate that greater precautions should be taken during contact with capuchin monkeys that have been in contact with rhesus as they may act as a source of BV infection for humans. We recommend that the housing of capuchins in close proximity to macaques should be avoided in zoos and in other facilities. With hindsight, we must admit that we have been fortunate in not having had a human case bearing in mind the close contact between our caretakers and capuchins. Testing captive primates for serious pathogens is essential to ensure adequate health and safety provision and protect other species.
